Evolution Securities, the investment banking business of Evolution Group Plc, has selected Blue Curve’s Sell-side Investment Research solution to support its growing equity research operation in London.
Blue Curve’s solution, consisting of its insight, create, process, comply and reach products, will be used by all of the in-house analysts at Evolution. The new processes will enable the production and distribution of the research at optimum quality levels without increasing costs as the size of Evolution’s operations and demands placed on the Research department increase, not least from the increase in regulation.
The selection of Blue Curve’s Sell-side Investment Research solution is seen as a key step towards meeting Evolution Securities' objective of becoming recognised as the leading investment bank and source of best advice on growing small and mid-capitalisation companies in the UK.
Evolution selected Blue Curve after evaluating other vendor solutions and consultancy offerings, deciding that Blue Curve gave the most advanced software architecture and functionality set. In addition, Blue Curve was seen to be committed to extending its solutions in response to changing market conditions.
“Blue Curve’s technology is grounded in a deep understanding of the research process. The functionality its software offers will enable our research function to expand in line with the continued increase in demand that we see in our market,” said Andy Yeo, head of research at Evolution Securities.
“Evolution is one of the most successful and dynamic investment banking operations currently producing research,” said Mark Robertson, chief executive officer of Blue Curve. “Our solution will lift Evolution’s research process above those of its competitors, and will ensure the company is fully compliant with current and future regulatory requirements laid down by the Financial Services Authority.”